Ventas, Inc. (VTR), an S&P 500 healthcare real estate investment trust (REIT), reported third quarter 2026 results on October 27, 2026. The company owns roughly 1,500 properties across North America and the United Kingdom, including approximately 1,000 senior housing communities. As a REIT, Ventas distributes most of its taxable income to shareholders, making operating cash-flow metrics like FFO more meaningful to investors than traditional net income. This quarter carries weight because it reflects how well Ventas is capturing secular demand from an aging population, the strength of its acquisition strategy, and its progress in reducing leverage. The results also test whether its large SHOP portfolio can sustain above-market growth at a time when interest rates and capital costs remain a focal point for the broader REIT sector. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
For the third quarter ended September 30, 2026, Ventas reported attributable net income of $0.13 per share, down from $0.14 per share a year earlier. Revenue of $1.83 billion exceeded the $1.77 billion consensus estimate. On the earnings measures REIT investors watch most closely, the company posted Nareit FFO of $1.01 per share, up 15% year over year, and Normalized FFO of $0.99 per share, up 10% from $0.90 in the prior-year quarter.
Total Company NOI (Net Operating Income) grew 18% year over year, while Same-Store Cash NOI rose 11%. The standout was the SHOP segment, where Same-Store Cash NOI increased 16%, driven by U.S. growth of 17%, a 5% gain in revenue per occupied room, and a 290-basis-point improvement in average occupancy. Ventas also strengthened its balance sheet, with Net Debt-to-Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) improving to 4.4x, and reported $4.5 billion in liquidity. From what I see, the SHOP momentum stands out as particularly encouraging here.
Heading into the report, sentiment around Ventas had been mixed, with the stock closing at $83.34 and down roughly 11% over the prior three months. Investors were focused on whether senior housing operating momentum would remain intact and whether continued acquisition activity could lift growth without straining the balance sheet. Following the release, the stock moved higher in after-hours trading, a sign that the market rewarded the revenue beat, double-digit Normalized FFO growth, and the upwardly revised full-year guidance. The GAAP (Generally Accepted Accounting Principles) net income figure of $0.13 per share came in below some headline estimates, but REIT investors typically weigh cash-flow-based measures like Normalized FFO more heavily, and those results were solidly positive.
Ventas raised its full-year 2026 guidance, now expecting attributable net income per share of $0.64 to $0.67, Nareit FFO of $3.83 to $3.86, and Normalized FFO of $3.87 to $3.90. Management attributed the increase primarily to accretive senior housing investment activity, partially offset by interest rates and foreign exchange effects.
Looking ahead, investors will want to monitor whether SHOP same-store growth can be sustained as occupancy and pricing continue to recover. Occupancy exceeding 90% in the U.S. SHOP portfolio signals tightening supply-demand dynamics, but wage costs and labor availability remain key variables for operating margins.
Capital allocation is another area to watch. The company has closed $5.2 billion of senior housing investments year to date and funded much of this activity with equity, settling 47.3 million shares under forward sale agreements. The pace and pricing of future acquisitions, along with any further equity issuance, will shape both earnings per share and the balance sheet trajectory.
Finally, interest rates and borrowing costs remain central to REIT valuation. Ventas's improving leverage ratio and ample liquidity provide flexibility, but sustained rate pressure could influence acquisition yields and financing economics. Guidance commentary on these factors will be a key signal in coming quarters. I’m watching this closely as the acquisition pace could influence how the story unfolds.
In my analysis of healthcare REITs like VTR, I frequently rely on Tickeron’s AI-powered platforms to cross-check patterns and signals. The AI Screener stands out for its ability to filter by fundamentals, technicals, and industry trends, helping me quickly identify comparable opportunities without spending hours on manual reviews. It integrates well with my broader workflow for spotting emerging signals in the sector.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 50-day moving average for VTR moved below the 200-day moving average on November 12, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VTR as a result. In 40 of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 49%.
The Moving Average Convergence Divergence Histogram (MACD) for VTR turned negative on November 19, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 20 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 51%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VTR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 51%.
The Aroon Indicator for VTR entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
VTR moved above its 50-day moving average on November 03, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for VTR crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 57%.
Following a +1.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where VTR advanced for three days, in 204 of 334 cases, the price rose further within the following month. The odds of a continued upward trend are 61%.
VTR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Profit vs. Risk Rating rating for this company is 20 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 58, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 38 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 51 (best 1 - 100 worst), indicating steady price growth. VTR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.108) is normal, around the industry mean (3.134). VTR's P/E Ratio (161.364) is considerably higher than the industry average of (30.791). VTR's Projected Growth (PEG Ratio) (4.961) is slightly higher than the industry average of (1.649). Dividend Yield (0.023) settles around the average of (0.050) among similar stocks. P/S Ratio (6.605) is also within normal values, averaging (6.013).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a real estate investment trust
Industry PublishingBooksMagazines